| Names | |
|---|---|
| Preferred IUPAC name (Z)-N1-[(2H-1,3-Benzodioxol-5-yl)methyl]-N′1-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-2-nitroethene-1,1-diamine | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.076.612 |
| EC Number |
|
| KEGG |
|
| MeSH | C073716 |
| UNII | |
| |
| |
| Properties | |
| C20H26N4O5S | |
| Molar mass | 434.51 g·mol−1 |
| Pharmacology | |
| A02BA05 (WHO) | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Niperotidine is ahistamine antagonist selective for theH2 subtype. It was studied as a treatment for excessive gastric acidity,[1] but withdrawn after human trials showedliver damage.[2]
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |